Literature DB >> 29766444

Toward a More Sensitive Endpoint for Assessing Postoperative Complications in Patients with Inflammatory Bowel Disease: a Comparison Between Comprehensive Complication Index (CCI) and Clavien-Dindo Classification (CDC).

Feng Zhu1, Dengyu Feng2, Tenghui Zhang2, Lili Gu2, Weiming Zhu2, Zhen Guo2, Yi Li2, Jianfeng Gong3,4, Ning Li2, Jieshou Li2.   

Abstract

BACKGROUND: The comprehensive complication index (CCI) is a novel approach to evaluate complications. However, application of the CCI in inflammatory bowel disease (IBD) population is scarce and the difference between the CCI and the Clavien-Dindo classification (CDC) remains unknown. The aim of this study was to compare the CCI to the conventional CDC by applying the CCI among the IBD patients.
METHODS: The data of 426 IBD patients who underwent surgery between September 1, 2015 and August 31, 2017 were collected. Univariate and multivariate analyses were conducted to identify risk factors for postoperative complications. The efficacy of CCI and CDC was compared using correlation analysis and logistic regression. Cumulative sum control (CUSUM) models were applied to monitor the CCI continuously.
RESULTS: Totally, 297 complications occurred in 144 (33.8%) patients. The rate of severe complications (CDC grade ≥ III) was 12.9% and the mean CCI was 9.8 ± 15.5. Preoperative glucocorticoids usage and previous abdominal surgery were related to higher CCI value (p = 0.002, p = 0.006, respectively) but not related to higher incidence of severe complications (CDC grade ≥ III) (p = 0.117, p = 0.177, respectively). In patients with multiple complications, the CCI demonstrated a stronger correlation with hospital stay (ρ = 0.604, p < 0.001) than CDC (ρ = 0.508, p < 0.001). Higher CCI value (p < 0.001, OR 1.161, 95% CI 1.093-1.234) and the CDC grade (p < 0.001, OR 3.811, 95% CI 2.283-6.362) were risk factors for prolonged LOS. In the CUSUM-CCI model of IBD surgery, a gradual decrease was observed over time.
CONCLUSIONS: The CCI and the CDC are both risk factors for prolonged postoperative LOS after surgery for IBD patients. The CCI is more strongly correlated with postoperative LOS than is the conventional CDC. The CUSUM-CCI model is effective in monitoring surgical quality.

Entities:  

Keywords:  Comprehensive complication index; Postoperative morbidity; Surgical quality monitoring

Mesh:

Substances:

Year:  2018        PMID: 29766444     DOI: 10.1007/s11605-018-3786-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  30 in total

1.  Indications for surgery in Crohn's disease: analysis of 500 cases.

Authors:  R G Farmer; W A Hawk; R B Turnbull
Journal:  Gastroenterology       Date:  1976-08       Impact factor: 22.682

2.  The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials.

Authors:  Ksenija Slankamenac; Nina Nederlof; Patrick Pessaux; Jeroen de Jonge; Bas P L Wijnhoven; Stefan Breitenstein; Christian E Oberkofler; Rolf Graf; Milo A Puhan; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2014-11       Impact factor: 12.969

3.  Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study.

Authors:  Takayuki Yamamoto; Antonino Spinelli; Yasuo Suzuki; Rogerio Saad-Hossne; Fabio Vieira Teixeira; Idblan Carvalho de Albuquerque; Rodolff Nunes da Silva; Ivan Folchini de Barcelos; Ken Takeuchi; Akihiro Yamada; Takahiro Shimoyama; Lorete Maria da Silva Kotze; Matteo Sacchi; Silvio Danese; Paulo Gustavo Kotze
Journal:  United European Gastroenterol J       Date:  2015-08-06       Impact factor: 4.623

Review 4.  Laparoscopy in Crohn's disease.

Authors:  Léon Maggiori; Yves Panis
Journal:  Best Pract Res Clin Gastroenterol       Date:  2013-12-01       Impact factor: 3.043

5.  Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients.

Authors:  Willem E Hueting; Erik Buskens; Ingeborg van der Tweel; Hein G Gooszen; Cees J H M van Laarhoven
Journal:  Dig Surg       Date:  2005-04-14       Impact factor: 2.588

6.  External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospective multicenter randomized trial.

Authors:  Patrick Pessaux; Alain Sauvanet; Christophe Mariette; François Paye; Fabrice Muscari; Antonio Sa Cunha; Bernard Sastre; Jean-Pierre Arnaud
Journal:  Ann Surg       Date:  2011-05       Impact factor: 12.969

7.  Postoperative Complications in Pediatric Inflammatory Bowel Disease: A Population-based Study.

Authors:  Eugénie Penninck; Mathurin Fumery; Laura Armengol-Debeir; Hélène Sarter; Guillaume Savoye; Dominique Turck; Guillaume Pineton de Chambrun; Francis Vasseur; Jean-Louis Dupas; Eric Lerebours; Jean-Frédéric Colombel; Laurent Peyrin-Biroulet; Corinne Gower-Rousseau
Journal:  Inflamm Bowel Dis       Date:  2016-01       Impact factor: 5.325

8.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Authors:  J Satsangi; M S Silverberg; S Vermeire; J-F Colombel
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

9.  Transanal Versus Transabdominal Minimally Invasive (Completion) Proctectomy With Ileal Pouch-anal Anastomosis in Ulcerative Colitis: A Comparative Study.

Authors:  Anthony de Buck van Overstraeten; Anders Mark-Christensen; Karin A Wasmann; Vivian P Bastiaenen; Christianne J Buskens; Albert M Wolthuis; Koen Vanbrabant; André D'hoore; Willem A Bemelman; Anders Tottrup; Pieter J Tanis
Journal:  Ann Surg       Date:  2017-11       Impact factor: 12.969

10.  Perioperative Use of Vedolizumab is not Associated with Postoperative Infectious Complications in Patients with Ulcerative Colitis Undergoing Colectomy.

Authors:  Marc Ferrante; Anthony de Buck van Overstraeten; Nikkie Schils; Annick Moens; Gert Van Assche; Albert Wolthuis; Séverine Vermeire; André D'Hoore
Journal:  J Crohns Colitis       Date:  2017-10-27       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.